BerGenBio ASA Competitors

(DDXS) (OTCMKTS:DDXS) and BerGenBio ASA (OTCMKTS:BRRGF) are both health technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and target prices for (DDXS) and BerGenBio ASA, as provided by MarketBeat.com.

Profitability

This table compares (DDXS) and BerGenBio ASA's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares (DDXS) and BerGenBio ASA's revenue, earnings per share and valuation.

Summary

BerGenBio ASA beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and BerGenBio ASA (OTCMKTS:BRRGF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (TNGN) and BerGenBio ASA, as provided by MarketBeat.

Profitability

This table compares (TNGN) and BerGenBio ASA's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares (TNGN) and BerGenBio ASA's top-line revenue, earnings per share and valuation.

Summary

BerGenBio ASA beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and BerGenBio ASA (OTCMKTS:BRRGF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Profitability

This table compares Abattis Bioceuticals and BerGenBio ASA's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Abattis Bioceuticals and BerGenBio ASA, as provided by MarketBeat.

Valuation and Earnings

This table compares Abattis Bioceuticals and BerGenBio ASA's top-line revenue, earnings per share and valuation.

Summary

BerGenBio ASA beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

BerGenBio ASA (OTCMKTS:BRRGF) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Profitability

This table compares BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings for BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares, as reported by MarketBeat.com.

Valuation & Earnings

This table compares BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares' top-line revenue, earnings per share (EPS) and valuation.

Summary

BerGenBio ASA beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.

BerGenBio ASA (OTCMKTS:BRRGF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares BerGenBio ASA and ADiTx Therapeutics' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares BerGenBio ASA and ADiTx Therapeutics' gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for BerGenBio ASA and ADiTx Therapeutics, as reported by MarketBeat.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and BerGenBio ASA (OTCMKTS:BRRGF) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Earnings and Valuation

This table compares Algernon Pharmaceuticals and BerGenBio ASA's revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Algernon Pharmaceuticals and BerGenBio ASA, as reported by MarketBeat.

Profitability

This table compares Algernon Pharmaceuticals and BerGenBio ASA's net margins, return on equity and return on assets.

Summary

BerGenBio ASA beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.